| Product Code: ETC088669 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Vietnam Radiopharmaceutical Market was estimated at USD 244 Million in 2025 and is projected to reach USD 345 Million by 2032, growing at a CAGR of 5.1% from 2026 to 2032. This upward trajectory is fueled by the expanding healthcare infrastructure and a rising prevalence of chronic diseases such as cancer and cardiovascular ailments. As medical imaging technologies continue to advance, the demand for radiopharmaceuticals to facilitate both diagnostic and therapeutic applications is poised for significant growth in the coming years.
The Vietnamese radiopharmaceutical market has showcased a dynamic growth pattern over the past few years, highlighted by an impressive 8.2% increase in 2023 following a more modest 2.7% in 2022. Factors such as rising healthcare investments, advancements in diagnostic imaging technology, and an increased prevalence of chronic diseases have spurred demand. The growth is poised to continue its upward trend, with forecasts of 6.9% in 2025 and 8.2% in 2026, reflecting robust consumer demand. However, fluctuations are anticipated, as seen with a 5.3% growth in 2031, likely due to evolving regulatory frameworks and potential market saturation. Overall, a wave of innovation supported by improved infrastructure is driving the sector forward.
This graph highlights how the Vietnam Radiopharmaceutical Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.6% | Technology integration streamlined radiopharmaceutical production and export processes |
| 2022 | 2.7% | Improved manufacturing facilities attract foreign direct investments in radiopharmaceuticals |
| 2023 | 8.2% | Radiopharmaceutical production efficiency drives export opportunities for Vietnam |
| 2024 | 5.3% | Foreign investment boosts domestic radiopharmaceutical manufacturing capabilities significantly |
| 2025 | 6.9% | Foreign investments in advanced radiopharmaceutical manufacturing enhance export capabilities |
| 2026 | 8.2% | Foreign investment in healthcare bolstered local radiopharmaceutical production capacity |
| 2027 | 7.1% | Pharmaceutical export agreements boosted local radiopharmaceutical production capabilities |
| 2028 | 6.8% | Foreign investments boost radiopharmaceutical production capacity and technology adoption |
| 2029 | 6.0% | Foreign investments in radiopharmaceuticals boost production capacity utilization |
| 2030 | 5.8% | Advanced manufacturing technologies streamline radiopharmaceutical production efficiency |
| 2031 | 5.3% | Foreign direct investments boosted local radiopharmaceutical manufacturing capabilities |
| 2032 | 5.5% | Foreign investments boost local radiopharmaceutical production capabilities |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The increasing integration of nuclear medicine into standard medical practices is reshaping the landscape of diagnostics and treatment in Vietnam. With radiopharmaceuticals being pivotal in enhancing diagnostic precision, the market is witnessing a surge in adoption among healthcare providers.
Moreover, as the Vietnamese government emphasizes healthcare development, investments are channeling into research and innovation in radiopharmaceuticals. This commitment is resulting in a diverse range of products that cater to various medical needs, reinforcing the market's growth momentum.
While the Vietnam Radiopharmaceutical Market shows promising growth potential, it faces several restraints that could impede progress. Regulatory hurdles related to the approval processes for new radiopharmaceuticals create a challenging environment for manufacturers. These regulatory frameworks often necessitate extensive safety compliance measures, which can lead to delays in market entry. Furthermore, the complex nature of radiopharmaceutical production, coupled with the need for advanced logistical capabilities to manage radioactive materials, poses significant operational challenges for stakeholders.
The landscape of the Vietnam Radiopharmaceutical Market is characterized by several notable trends. The shift toward personalized medicine is gaining traction, prompting the development of tailored radiopharmaceuticals for specific patient populations. Additionally, digital health technologies are beginning to intertwine with nuclear medicine, improving patient management and diagnostic accuracy through enhanced data analytics.
Furthermore, there is a growing emphasis on the sustainability of radiopharmaceuticals, with companies exploring eco-friendly manufacturing processes. These trends are reflective of broader shifts in the healthcare sector towards innovation, efficiency, and environmental responsibility.
The opportunities within the Vietnam Radiopharmaceutical Market are ripe for exploration. Investment in research and development is crucial, as it can lead to breakthroughs in radiopharmaceutical formulations that improve diagnostic and therapeutic outcomes. Additionally, public-private partnerships can further enhance the infrastructure required for safe handling and distribution of radiopharmaceuticals, creating pathways for new market entrants.
As Vietnam continues to modernize its healthcare system, there is a clear opportunity for increased collaboration with international firms specializing in advanced nuclear medicine technologies. Such collaborations could accelerate the introduction of novel products and methods, catering to the evolving needs of the healthcare landscape.
The Vietnamese government plays a pivotal role in the advancement of the radiopharmaceutical sector. Initiatives aimed at strengthening healthcare infrastructure have been implemented, including increased funding for research institutions and hospitals. Additionally, policies promoting international collaboration are fostering knowledge exchange and technology transfer, essential for the development of the radiopharmaceutical market.
Such government efforts are geared towards creating a conducive environment for innovation, regulatory compliance, and public health enhancements, ultimately contributing to the growth and stability of the radiopharmaceutical industry.
Looking ahead to 2026-2032, the Vietnam Radiopharmaceutical Market is expected to continue on its growth trajectory, propelled by ongoing advancements in technology and an increasingly proactive healthcare policy environment. The integration of radiopharmaceuticals into broader healthcare strategies will further solidify their importance in clinical applications.
Moreover, as Vietnam's population ages and chronic disease prevalence rises, demand for innovative radiopharmaceuticals for both diagnostics and treatment is likely to expand. The market's ability to adapt to evolving healthcare needs will determine its future success.
Recent developments in the Vietnam Radiopharmaceutical Market indicate a robust focus on expanding local production capabilities. New partnerships are being formed between domestic manufacturers and international experts to enhance the quality and safety of radiopharmaceutical products. Additionally, ongoing clinical trials for novel diagnostic agents highlight the market's commitment to innovation and meeting patient needs.
Furthermore, the evolution of regulatory frameworks is facilitating a more efficient approval process for new radiopharmaceuticals, paving the way for quicker market entries and greater diversity in treatment options.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Radiopharmaceutical Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Radiopharmaceutical Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Radiopharmaceutical Market - Industry Life Cycle |
3.4 Vietnam Radiopharmaceutical Market - Porter's Five Forces |
3.5 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By Types, 2022 & 2032F |
3.6 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2022 & 2032F |
3.8 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By Source, 2022 & 2032F |
3.9 Vietnam Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Vietnam Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases leading to higher demand for diagnostic imaging procedures using radiopharmaceuticals |
4.2.2 Growing investments in healthcare infrastructure and facilities in Vietnam |
4.2.3 Rising awareness about the benefits of nuclear medicine and radiopharmaceuticals among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Lack of skilled professionals in the field of nuclear medicine and radiopharmaceuticals |
4.3.2 Stringent regulatory requirements and approval processes for radiopharmaceuticals in Vietnam |
4.3.3 Limited reimbursement options for radiopharmaceutical procedures in the healthcare system |
5 Vietnam Radiopharmaceutical Market Trends |
6 Vietnam Radiopharmaceutical Market, By Types |
6.1 Vietnam Radiopharmaceutical Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Types, 2022-2032F |
6.1.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2022-2032F |
6.1.4 Vietnam Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2022-2032F |
6.2 Vietnam Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2022-2032F |
6.2.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2022-2032F |
6.3 Vietnam Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2022-2032F |
6.3.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2022-2032F |
6.4 Vietnam Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2022-2032F |
6.4.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2022-2032F |
6.5 Vietnam Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2022-2032F |
6.5.3 Vietnam Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2022-2032F |
6.5.4 Vietnam Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2022-2032F |
6.5.5 Vietnam Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2022-2032F |
6.5.6 Vietnam Radiopharmaceutical Market Revenues & Volume, By Others, 2022-2032F |
7 Vietnam Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Vietnam Radiopharmaceutical Market Export to Major Countries |
7.2 Vietnam Radiopharmaceutical Market Imports from Major Countries |
8 Vietnam Radiopharmaceutical Market Key Performance Indicators |
8.1 Number of new nuclear medicine facilities or departments established in Vietnam |
8.2 Percentage increase in the adoption of advanced radiopharmaceutical imaging technologies |
8.3 Average waiting time for patients to undergo radiopharmaceutical procedures |
9 Vietnam Radiopharmaceutical Market - Opportunity Assessment |
9.1 Vietnam Radiopharmaceutical Market Opportunity Assessment, By Types, 2022 & 2032F |
9.2 Vietnam Radiopharmaceutical Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 Vietnam Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2022 & 2032F |
9.4 Vietnam Radiopharmaceutical Market Opportunity Assessment, By Source, 2022 & 2032F |
9.5 Vietnam Radiopharmaceutical Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Vietnam Radiopharmaceutical Market - Competitive Landscape |
10.1 Vietnam Radiopharmaceutical Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here